Cartesian Therapeutics (RNAC) reported a “watershed moment” for its autoimmune-disease focused CAR-T treatment on Tuesday, but the biotech stock plunged. ↑ X NOW PLAYING CRSP Stock...
Moderna (MRNA) stock tumbled Wednesday after the company said its newly approved RSV vaccine was only about 50% effective after 18 months — paling in comparison...
Alnylam stock catapulted Monday, breaking out from a lengthy consolidation, after its experimental heart-disease treatment topped expectations in a highly anticipated study. ↑ X NOW PLAYING...